Evaluation of the clinical equivalence of biosimilars to their reference drugs in the treatment of rheumatoid arthritis: a Meta-analysis
1Institute of Public Health, Peking University, Beijing 100191, China
2Peking University Center for Evidence Based Medical and Clinical Research, Beijing 100191, China
3Key Laboratory, the Second Affiliated Hospital of Kunming Medical University, Kunming 650011, China
4Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong 999077, China
收起